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Abstract: OBJECTIVE: To retrospectively evaluate if texture-based radiomics features are able to detect
interstitial lung disease (ILD) and to distinguish between the different disease stages in patients with
systemic sclerosis (SSc) in comparison with mere visual analysis of high-resolution computed tomography
(HRCT). METHODS: Sixty patients (46 females, median age 56 years) with SSc who underwent HRCT
of the thorax were retrospectively analyzed. Visual analysis was performed by two radiologists for the
presence of ILD features. Gender, age, and pulmonary function (GAP) stage was calculated from clinical
data (gender, age, pulmonary function test). Data augmentation was performed and the balanced dataset
was split into a training (70%) and a testing dataset (30%). For selecting variables that allow classification
of the GAP stage, single and multiple logistic regression models were fitted and compared by using the
Akaike information criterion (AIC). Diagnostic accuracy was evaluated from the area under the curve
(AUC) from receiver operating characteristic (ROC) analyses, and diagnostic sensitivity and specificity
were calculated. RESULTS: Values for some radiomics features were significantly lower (p < 0.05) and
those of other radiomics features were significantly higher (p = 0.001) in patients with GAP2 compared
with those in patients with GAP1. The combination of two specific radiomics features in a multivariable
model resulted in the lowest AIC of 10.73 with an AUC of 0.96, 84% sensitivity, and 99% specificity. Visual
assessment of fibrosis was inferior in predicting individual GAP stages (AUC 0.86; 83% sensitivity; 74%
specificity). CONCLUSION: The correlation of radiomics with GAP stage, but not with the visually
defined features of ILD-HRCT, implies that radiomics might capture features indicating severity of SSc-
ILD on HRCT, which are not recognized by visual analysis. KEY POINTS: Radiomics features can
predict GAP stage with a sensitivity of 84% and a specificity of almost 100%. • Extent of fibrosis on
HRCT and a combined model of different visual HRCT-ILD features perform worse in predicting GAP
stage. • The correlation of radiomics with GAP stage, but not with the visually defined features of
ILD-HRCT, implies that radiomics might capture features on HRCT, which are not recognized by visual
analysis.
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Abstract
Objective To retrospectively evaluate if texture-based radiomics features are able to detect interstitial lung disease (ILD) and to
distinguish between the different disease stages in patients with systemic sclerosis (SSc) in comparison with mere visual analysis
of high-resolution computed tomography (HRCT).
Methods Sixty patients (46 females, median age 56 years) with SSc who underwent HRCT of the thorax were retrospectively
analyzed. Visual analysis was performed by two radiologists for the presence of ILD features. Gender, age, and pulmonary function
(GAP) stage was calculated from clinical data (gender, age, pulmonary function test). Data augmentation was performed and the
balanced dataset was split into a training (70%) and a testing dataset (30%). For selecting variables that allow classification of the GAP
stage, single and multiple logistic regression models were fitted and compared by using the Akaike information criterion (AIC).
Diagnostic accuracy was evaluated from the area under the curve (AUC) from receiver operating characteristic (ROC) analyses, and
diagnostic sensitivity and specificity were calculated.
Results Values for some radiomics features were significantly lower (p < 0.05) and those of other radiomics features were significantly
higher (p = 0.001) in patients with GAP2 compared with those in patients with GAP1. The combination of two specific radiomics
features in amultivariablemodel resulted in the lowest AIC of 10.73with anAUCof 0.96, 84% sensitivity, and 99% specificity. Visual
assessment of fibrosis was inferior in predicting individual GAP stages (AUC 0.86; 83% sensitivity; 74% specificity).
Conclusion The correlation of radiomics with GAP stage, but not with the visually defined features of ILD-HRCT, implies that
radiomics might capture features indicating severity of SSc-ILD on HRCT, which are not recognized by visual analysis.
Key Points
• Radiomics features can predict GAP stage with a sensitivity of 84% and a specificity of almost 100%.
• Extent of fibrosis on HRCT and a combined model of different visual HRCT-ILD features perform worse in predicting GAP stage.
• The correlation of radiomics with GAP stage, but not with the visually defined features of ILD-HRCT, implies that radiomics
might capture features on HRCT, which are not recognized by visual analysis.
Keywords Systemic sclerosis . Pulmonary fibrosis . Artificial intelligence
Abbreviations
GAP stage Gender, age, and pulmonary function stage
HRCT High-resolution computed tomography
ILD Interstitial lung disease
SSc Systemic sclerosis
Introduction
Interstitial lung disease (ILD) is a well-known complication of
systemic sclerosis (SSc) affecting over 60% of patients [1–3]
and represents the leading cause of disease-related death [4].
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The detection of SSc-ILD is crucial because an early diag-
nosis of SSc-ILD has important prognostic and therapeutic
implications. Novel imaging approaches such as quantitative
computed tomography (CT) [5, 6], magnetic resonance imag-
ing (MRI) [7, 8], and nuclear imaging [9, 10] are applied in
ILD to provide prognostic, functional, and metabolic informa-
tion [11]. So far, high-resolution CT (HRCT), a non-invasive,
cost-effective, and sensitive technique, remains the gold stan-
dard for ILD diagnosis because it is able to detect lung in-
volvement prior to appearance of clinical symptoms and pro-
vides prognostic information [12–14]. However, there are
many features to determine the presence of ILD and inter-
reader variability, especially in unexperienced readers, is an
issue.
Most patients with SSc-ILD have mild or stable disease,
which does not warrant treatment, only surveillance [15].
However, the high morbidity and mortality of progressive
SSc-ILD define the need for early detection for therapeutic
intervention. Such a screening modality should combine both
high sensitivity and reproducibility.
Radiomics, defined as the conversion of medical images to
higher-dimensional data, is a novel research area. Feature ex-
traction is a crucial step in radiomics and comprises the com-
putation of texture, density, and shape from predefined re-
gions of interest (ROIs). Radiomics offers the advantage of
an objective quantification of tissue characteristics and en-
ables the detection of abnormalities in radiological images
not depicted by routine visual analysis [16–19]. Due to the
high objectivity and reliability of data, radiomics shows great
potential as support for clinical decision-making [20].
Radiomics has attracted increased attention in recent years,
and several studies show that radiomics can be of benefit in
terms of prognosis and diagnosis of multiple diseases, espe-
cially malignancies [21–23]. In SSc-ILD, to the best of our
knowledge, radiomics analyses have not yet been performed.
Currently, no validated single tools are established for stag-
ing in SSc-ILD although in clinical practice, a 70% threshold
of percentage predicted forced vital capacity (FVC [%]) and
extent of fibrosis on HRCT with a threshold of 20% are rou-
tinely used [13, 24]. Although most commonly employed,
pulmonary function tests as “stand-alone” examination are
inferior for diagnostic purposes than HRCT [2]. To overcome
the limitations of single factors, several composite scores have
been proposed: One of them is the so-called gender, age, and
pulmonary function (GAP) score and staging system, devel-
oped by Ley et al in 2012 [25]. The system uses four variables:
gender (G), age (A), and two pulmonary physiological param-
eters (P)—FVC [%] and percentage predicted diffusion capac-
ity of the lungs for carbon monoxide (DLCO [%]). The score
has been validated in the USA, Italy, and South Korea and
showed robust predictive power in patients with chronic ILD
[26, 27]. GAP stage is not routinely calculated in SSc-ILD,
and visual analysis of ILD criteria on HRCT does not, or not
sufficiently, reflect prognosis. We hypothesize that radiomics
features might provide important information on disease ex-
tent and could potentially influence individual patient
management.
In this retrospective pilot study, we aim to evaluate if
texture-based radiomics features are able to detect ILD and
to distinguish between the different disease stages in patients




Sixty patients (46 females, median age 56 years), who were
part of the SSc cohort at the University Hospital Zurich,
Switzerland (EUSTAR online Database [pre-BASEC-EK-
839, BASEC KEK-Nr.-2016-01515] and VEDOSS online
Database [BASEC-Nr.2010-158/5]), fulfilled the ACR/
EULAR classification criteria [28], and underwent HRCT
(Table 1) between January 2012 and October 2015 with signs
of ILD, were retrospectively included in the study. The corre-
sponding image analysis was done retrospectively.
Demographic and clinical data, as well as values for pulmo-
nary function tests (PFT), were acquired for each patient
(Table 1). The PFT indices included the actual values and
the percentage predicted values of a certain age, height, and
gender group (%predicted) of forced expiratory volume in 1 s
(FEV1), forced vital capacity (FVC), total lung capacity
(TLC), and diffusion capacity of carbon monoxide (DCLO).
In order to make results comparable throughout the study
population, %predicted values were used for statistical evalu-
ation. GAP stage was calculated according toMango et al [25,
29]. Patient characteristics are summarized in Table 1. The
retrospective study has been approved by the institutional re-
view board (BASEC-Nr. 2018-02165), and written informed
consent was sought from all patients.
HRCT protocol
All HRCT images were acquired in prone position in full
inspiration. HRCT scans were obtained with a 64-slice CT
scanner (Somatom Definition AS, Siemens Healthineers).
The CT protocol included a topogram and one series in prone
position in full inspiration. The following parameters were
used for the standard HRCT: tube voltage 120 kV, tube cur-
rent 30 mAs (reference dose, care dose: on), slice thickness: 1
mm, increment: 0.8 mm, kernel B70. The standard HRCTwas
reconstructed with iterative reconstruction (SAFIRE) strength
3 [30].
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ILD features on HRCT
The readout was performed by two radiologists (T.F. 16
and K.M. 5 years of experience in thoracic imaging) by
consensus: If there was disagreement between the two
readers, whether an HRCT feature was present or not,
re-assessment was performed until consensus was
reached. Images where evaluated for the presence of char-
acteristic visual ILD features (yes/no) including pulmo-
nary emphysema, honeycombing, subpleural lines, pleural
margins, bronchiectasis, ground-glass opacities, and retic-
ular changes (Fig. 1). A case-by-case evaluation was
performed.
Image analysis was performed on a standard picture archiv-
ing and communication system workstation (Impax, Version
6.5.5.1033; Agfa-Gevaert) and a high-definition liquid crystal
display monitor (BARCO; Medical Imaging Systems).
Visual assessment of lung fibrosis severity
Extent of lung fibrosis
According to Goh et al [13], estimation of disease extent de-
fined as definitely less than 20% (mild disease extent) or def-
initely more than 20% (severe disease extent) was performed.
All sections from the lung apex to the hemidiaphragm were
evaluated. In order to keep results specific for visual analysis,
we did not include the FVC threshold of 70% proposed by
Goh et al [13] in cases with an indeterminate extent of disease
on HRCT.
Table 1 Main patient
characteristics. n number of
patients, f/m female/male, y/n yes/
no, SD standard deviation, mRSS
modified Rodnan skin score, ILD
interstitial lung disease, HRCT
high-resolution computed tomog-
raphy. The PFT indices included
the percentage predicted values of
a certain age, height, and gender
group (%predicted) of forced ex-
piratory volume in 1 s (FEV1),
forced vital capacity (FVC), total
lung capacity (TLC), and diffu-
sion capacity of carbon monoxide
(DCLO). Percentage of fibrosis
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Patient information GAP1 GAP2 p value
Demographics
Number (n) 54 6
Gender (f/m) 48/6 4/2 0.129
Median age (range) 58 (23–82) 68 (54–80) 0.022
Mean mRSS score (range) 5.7 (0–31) 11.7 (0–22) 0.176
Disease subset
Limited cutaneous 22 (37%) 4 (67%) 0.224
Diffuse cutaneous 10 (17%) 1 (17%) > 0.999
Sclerodactyly only 17 (28%) 1 (17%) 0.452
Sine scleroderma 4 (7%) 0 (0%) 0.687
Other organ manifestations
GIT 33 (55%) 4 (67%) 0.791
Renal crisis 0 (0%) 0 (0%) > 0.999
Pulmonary arterial hypertension*** 10 (27%) 3 (50%) 0.076
Cardiac involvement 24 (40%) 1 (17%) 0.190
Auto-abs* 54 (100%) 6 (100%) > 0.999
Immunomodulatory therapy** 54 (100%) 6 (100%) > 0.999
Lung function
FEV1% (mean ± SD) 93 ± 16 61 ± 11 < 0.001
FVC% (mean ± SD) 98 ± 18 65 ± 26 0.035
TLC% (mean ± SD) 94 ± 21 57 ± 23 0.013
DCLO% (mean ± SD) 79 ± 19 56 ± 23 0.076
Features of ILD on HRCT
Pulmonary emphysema (y/n) 5 (8%) 3 (50%) 0.005
Honeycombing (y/n) 5 (8%) 3 (50%) 0.005
Subpleural lines (y/n) 46 (77%) 6 (100%) 0.311
Bronchiectasis (y/n) 19 (32%) 5 (83%) 0.022
Ground-glass opacities (y/n) 25 (42%) 4 (67%) 0.344
Reticular changes (y/n) 46 (77%) 6 (100%) 0.311
Pleural margins (y/n) 31 (52%) 5 (50%) 0.219
Mean coarseness score (± SD) 11.8 (± 3.3) 16.8 (± 3.3) 0.001
Fibrosis > 20% on HRCT (y/n) 8 (13%) 3 (50%) 0.257
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Pulmonary fibrosis was defined as presence of reticular
changes, honeycombing, or both.
Coarseness of lung fibrosis
The most extensive parenchymal pattern in each lobe was
recorded as categorical coarseness grade 0, normal lung;
grade 1, ground-glass opacity; grade 2, fine reticulation;
grade 3, coarse reticulation; and grade 4, honeycombing.
The primary coarseness score represented the sum of
coarseness grades (grade 0–4). To remove the effect of
pattern extent and prevent the underestimation of coarse-
ness severity in patients, in whom some lobes had no
parenchymal abnormality, the score was adjusted propor-
tionally to a six-lobe score [31]:
CS ¼ ∑n1−n CGð Þ=LILD*6
where n is the number of lobes, CS is the coarseness
score, CG is the coarseness grade, and LILD is the number
of lobes with ILD.
Radiomics
3D lung segmentation
We chose to segment only the right lung, since the presence of
the heart on the left side potentially makes lung segmentation
more difficult and may lead to alteration of results. The right
lung of each patient was segmented semi-automatically with
dedicated softwareMIM (Version 6.0,MIM Software Inc.) by
setting the Hounsfield unit (HU) values from − 950 to − 150
HU. Where automatically registered borders did not corre-
spond with lung borders, manual corrections were made.
The hilar vessels were carefully excluded.
Extraction of texture features
Prior to analysis, all images were resampled to isotropic
voxels of 2 mm, using linear interpolation [32]. In total,
1116 features were extracted with two bin sizes (10 and 35
HU) corresponding to the following feature classes [33]:
– 4 shape features
– 19 intensity features
– 105 texture features (52 from the gray-level co-occur-
rence matrix, 5 from the neighborhood gray-tone differ-
encematrix, 32 from the gray-level run lengthmatrix, and
16 from the gray-level size zone matrix)
– 976 wavelet features (coiflet filtering)
Feature descriptions and mathematical definitions were
used as described (see the Supplemental Material).
Data augmentation
Data augmentation was performed using the imbalance pack-
age in R (version 3.4.0; R Foundation for Statistical
Computing) and applying a majority weighted minority
oversampling technique (MWMOTE) (details can be found
in the Supplemental Material). After applying the
MWMOTE technique, the dataset consisted of an equal num-
ber of GAP1 (n = 54) and GAP2 (n = 54) stage patients. An
example of data oversampling and resulting feature values is
shown in the Supplemental Material.
Splitting of the dataset into training and testing
datasets
In order to ensure the generalizability of the trained statistical
models, the balanced dataset was then randomly split into
separate training (n = 76 patients, n = 38 GAP1 and n = 38
GAP2) and testing dataset (n = 32 patients, n = 16 GAP1 and
n = 16 GAP2) using a ratio of 0.7:0.3. The entire dimension
reduction and feature selection process as further described in
Fig. 1 Features of interstitial lung disease (ILD) on high-resolution com-
puted tomography (HRCT)
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the “Results” section was performed only on the training
dataset.
Statistical analysis
Statistical analysis was performed in R (version 3.4.0; R
Foundation for Statistical Computing) with RStudio (version
1.0.136; RStudio). R packages used for statistical analysis are
described in the Supplemental Material. All continuous data
are given as means ± standard deviation. Categorical variables
are expressed as frequencies or percentages. A two-tailed p
value of < 0.05 was considered to indicate statistical signifi-
cance. Testing for group differences was performed by using
Wilcoxon’s signed-rank tests and Friedman’s test after
assessing normal distribution of the data. The chi-squared test
was used to compare categorical parameters.
For selecting variables that allow classification of GAP
stages 1 and 2, single and multiple logistic regression models
were fitted and compared by using the Akaike information
criterion (AIC). The misclassification rate of these models
was assessed by using 10-fold cross-validation. The diagnos-
tic accuracy of optimal predictive parameters was evaluated
from the area under the curve (AUC) from receiver operating
characteristic (ROC) analyses, and diagnostic sensitivity and
specificity were calculated.
Similarly, predictive value of ILD-HRCT features for the
GAP stage was tested.
Results
Visual assessment of HRCT
In 17 out of the 60 cases, readers disagreed about the presence
of ILD features. In these cases, disagreement was resolved in
consensus reading.
Eight patients showed pulmonary emphysema (13%), eight
honeycombing (13%), 52 subpleural lines (87%), 24 bronchi-
ectasis (40%), 29 ground-glass opacities (48%), 52 reticular
changes (87%), 36 pleural margins (60%), and 11 fibrosis
involving more than 20% of the lung parenchyma (18%).
Mean coarseness score was 12.3 (SD ± 3.6).
For detailed information and distribution of the features
among GAP stages, please refer to Table 1 and Fig. 2.
Highest AUC could be obtained when combining
honeycombing, emphysema, and bronchiectasis in a model,
which resulted in an AUC of 0.86 with a sensitivity of 100%
and a specificity of 63%.When performing ROC analysis, the
AUC for predicting GAP stage with extent of fibrosis (fibrosis
> 20%) is 0.606 (95% confidence interval 0.543–0.791, p =
0.145) with a sensitivity of 50% and a specificity of 85.2%.
When performing ROC analysis for coarseness score of
fibrosis, the AUC for predicting GAP stage reached 0.863
(95% confidence interval 0.703–1.000, p = 0.004) with a sen-
sitivity of 83% and a specificity of 74%. Differences between
predicting ROC curves with extent of fibrosis versus coarse-
ness of fibrosis were not statistically significant (p = 0.057).
Radiomics
Dimension reduction and radiomics feature selection
for classification of GAP1 versus GAP2 stage
Radiomics feature selection and dimension reduction were
performed on the augmented training dataset. After normali-
zation of all numeric features using z-score standardization,
features were fed into the Boruta dimension reduction and
feature elimination algorithm as described previously [25,
26], resulting in the selection of 73 features, which were con-
sidered most important for classification accuracy. Since the
Boruta algorithm does not account for collinearity in the data,
a correlation matrix was calculated in a next step in order to
detect clusters of highly correlated features (defined as
Pearson’s r ≥ .60; Fig. 3). After visualization of each single
parameter in box and whisker plots and random forest models
fitted separately on each of the six detected correlation clus-
ters, only one feature from each cluster with the highest Gini
index and visually the best separation between the two groups
(“GAP1” and “GAP2” stage) was selected for further analysis.
At the end of the multistep dimension reduction process, the
six most important and independent features were selected for
further statistical analyses: M_homogenity_n.LHL,
neighContrast.LHL, fractal_dim.LLL, M_correlation.HLL,
M_correlation.HHL, and sizeVar_n.LLH.
Training of statistical models for classification of GAP1 versus
GAP2 stage
In the original non-augmented dataset, values for
M_homogeni ty_n.LHL, M_correla t ion.HLL, and
sizeVar_n.LLH were significantly lower in patients with a
GAP stage of 2 when compared with those in patients with a
GAP stage of 1 (p = 0.003, 0.001, and 0.007, respectively;
Fig. 4 and Table 2). In contrast, values for neighContrast.LHL
were significantly higher in patients with a GAP stage of 2 (p
= 0.001). No significant differences were observed for
fractal_dim.LLL and correlation.HHL, although the differ-
ence for fractal_dim.LLL reached statistical significance in
the augmented dataset.
Single and multiple logistic regression models were fitted
on the training dataset and compared according to their AIC.
In single logistic regression models, M_homogenity_n.LHL
and neighContrast.LHL showed the lowest AIC with 21.13
and 23.81, respectively (fractal_dim.LLL: 98.37,
M_correlation.HLL: 41.50, correlation.HHL: 107.16, and
sizeVar_n.LLH: 75.59). Results of the corresponding ROC
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Fig. 3 Correlogram illustrating
auto- and cross-correlations of the
73 most important features in dif-
ferentiating GAP1 and GAP2
stages. Features were reordered
after hierarchical clustering for
visualizing different feature clus-
ters. Six clusters of radiomics
features became apparent (rectan-
gular boxes; the first two clusters
were visually assumed to belong
to the same cluster). Blue circles
indicate positive correlation, and
red circles negative correlation.
The larger the circle and the
darker the color, the higher is the
correlation between two variables
Fig. 2 Varying grades of fibrosis
within the same GAP stages.
Patients with a, b GAP stage 1
and c, d GAP stage 2. a A 43-
year-old female patient with
GAP1 shows subpleural reticula-
tions, subpleural lines, and some
ground-glass opacification—
overall less than 10% of fibrosis.
b A 56-year-old female patient
with GAP1 shows basal and
subpleural reticulations, ground-
glass opacities, and subpleural
lines accounting for more than
20% of lung fibrosis. cA 69-year-
old female patient with GAP2
shows only discrete subpleural
lines. No other signs of fibrosis
are visualized. d An 80-year-old




and pleural margins in the right
lung
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analyses for the training, testing, and the original (non-
augmented) datasets are shown in Table 3.
C o m b i n i n g M _ h o m o g e n i t y _ n . L H L a n d
neighContrast.LHL in a model resulted in a higher AIC
(21.94) and showed collinearity of the two features without
significant improvement of diagnostic sensitivity and specific-
i ty. The combinat ion of neighContrast .LHL and
M_correlation.HLL in a multivariable model finally resulted
Fig. 4 Box and whisker plots
show differences of the 6 most
important radiomics features
selected during the multistep
dimension reduction and feature
selection process between GAP1
and GAP2 patients. Center line in
each box represents median.
Lower and upper limits of each
box represent the 25th and 75th
percentiles, respectively.
Whiskers extend to most extreme
observations within 25th and 75th
percentiles ± 1.5 × interquartile
range. Observations outside these
whiskers are shown as dots
Table 2 Results of radiomics. GAP stage gender, age, and pulmonary function stage, n number of patients
Variable GAP1 (n = 54) GAP2
(original; n = 6)
GAP2







M_homogenity_n.LHL 0.73 ± 0.14 0.33 ± 0.27 0.25 ± 0.18 .003 < 0.001
neighContrast.LHL 0.31 ± 0.17 0.77 ± 0.26 0.81 ± 0.15 .001 < 0.001
fractal_dim.LLL 0.58 ± 0.20 0.39 ± 0.39 0.36 ± 0.25 .171 < 0.001
M_correlation.HLL 0.49 ± 0.21 0.18 ± 0.09 0.16 ± 0.07 .001 < 0.001
correlation.HHL 0.49 ± 0.20 0.57 ± 0.11 0.54 ± 0.07 .235 0.057
sizeVar_n.LLH 0.47 ± 0.22 0.22 ± 0.10 0.21 ± 0.06 .007 < 0.001
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in the lowest AIC of 10.73 with an AUC of 1.00, 100% sen-
sitivity, and 97% specificity in the training dataset; an AUC of
0.92, 100% sensitivity, and 88% specificity in the test dataset;
and an AUC of 0.96, 84% sensitivity, and 99% specificity in
the original dataset (Fig. 5 and Table 3).
Ten-fold cross-validation of this model in the independent
test dataset resulted in a cross-validation estimate of an accu-
racy of 0.88 (95% confidence interval 0.71–0.97).
Discussion
HRCT imaging together with PFT is currently the gold
standard for a cost-effective, non-invasive assessment of
ILD [34]. However, features to determine the presence of
ILD are manifold and inter-reader variability, especially
in unexperienced readers, is an issue. Radiomics, in con-
trast, is an objective imaging-based tool that enables a
more detailed and reliable quantitative assessment of le-
sion characteristics, which is not hampered by subjective
image interpretation and experience of the reader as in
visual analysis.
In this study, we were able to show that radiomics features
can predict GAP stage with a sensitivity of 84% and a speci-
ficity of almost 100%. Extent of fibrosis on HRCT and a
combined model of different visual HRCT-ILD features per-
formed worse in predicting GAP stage. We believe that this is
due to the high inter-reader variability, even in expert radiol-
ogists, in determining the presence and severity of ILD
features.
Since the dataset in our patient cohort was imbalanced
regarding the distribution of the two classes with 54 patients
in GAP1 stage, but only six patients in GAP2 stage (imbal-
anced ratio: 0.11)—thereby reflecting the prevalence of GAP1
versus GAP2 stages in our cohort of SSc patients—we per-
formed a data augmentation step in order to achieve better
class balance and to avoid model overfitting before further
evaluation. This data augmentation technique does not affect
the reliability of the statistical evaluation, and results have
been additionally tested on the original dataset.
Extracted radiomics features can be divided into four
groups, namely (1) first-order histogram-based features, (2)
co-occurrence matrix-based features, (3) multiscale features,
and (4) other features [35, 36]. The latter are part of a specific
group of features that are related to neighborhood gray-tone
difference matrix (GTDM) [35, 37, 38]. The GTDM is based
on measuring the difference between the intensity level be-
tween each voxel and its neighboring voxels, resulting in fea-
tures to resemble the human perception of the image.
Homogeneity (M_homogenity_n.LHL) reflects the homoge-
neity of image textures and scales the local changes of image
texture. High values of homogeneity denote the absence of
intra-regional changes and locally homogenous distribution
in image textures [39]. Fractal features (fractal_dim.LLL) pro-
v i d e impo r t a n t s p a t i a l i n f o rma t i o n . Con t r a s t
(neighContrast.LHL) and correlation (M_correlation.HLL
and correlation.HHL) rely on perceptual attributes of texture
in terms of spatial changes in intensity or dynamic range of
intensity [35, 37, 38]. In our study, the combination of
neighContrast.LHL and M_correlation.HLL in a multivari-
able model resulted in an AUC of 0.92, 100% sensitivity,
and 88% specificity in the test dataset and an AUC of 0.96,
84% sensitivity, and 99% specificity in the original dataset.
AUC of the ROC curve for percentage of fibrosis was signif-
icantly worse in predicting GAP stage, and also, a model
combining different HRCT-ILD features performed less well
than radiomics did. These findings raise the question, if
radiomics is able to capture features on HRCT which are not
perceptible by the radiologist with the naked eye?
Radiomics has attracted increased attention in recent years,
and several studies show that radiomics can be of benefit in
terms of prognosis and diagnosis of multiple diseases,
Fig. 5 Graphs show receiver operating characteristics (ROC) analyses for
the best classifying models of GAP1 versus GAP2 stage. ROC analysis
indicates accuracy, sensitivity, and specificity of the best performing
models applied on the (a) independent testing dataset and on the (b)
original (non-augmented) dataset. Panel c showing ROC analyses for
classifying GAP stage with visual analysis of extent of fibrosis (fibrosis
> 20%) and coarseness of fibrosis
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especially malignancies [21–23]. These studies have shown
that radiomics features show great potential to serve as surro-
gate imaging markers for tissue biopsies [40] and reliably
predict outcome [41–44] and drug response [45, 46].
Currently, there are different approaches for the evaluation
of HRCT, namely (1) visual analysis, (2) semiquantitative
analysis, and (3) quantitative analysis or automated ap-
proaches using artificial intelligence. While sheer visual anal-
ysis suffers from a relatively high inter-observer variability
[47, 48], semiquantitative and quantitative analyses (such as
densitometric analysis) have the potential to overcome the
drawbacks of subjective visual assessment of CT images and
have also been shown to correlate with therapeutic response
outperforming qualitative analysis [48].
In the past decade, radiomics gained importance in medical
imaging. Unlike computer-aided detection (CAD) systems,
which are directed toward delivering a single answer (i.e.,
presence of a lesion or cancer), radiomics is a process de-
signed to extract a large number of quantitative features from
digital images, which are subsequently mined for hypothesis
generation and testing. Recent data from non-malignant lung
diseases suggest that the texture-based analysis of CT data
might outperform the currently used visual and/or histogram
measures for diagnosis and staging [49–51]. The process of
radiomics-based stratification of data provides a far more de-
tailed characterization of phenotypes than current criteria can.
Compared with other studies [52], we did not train the
algorithm to recognize specific patterns or features, such as
honeycombing or bronchiectasis. We trained the system to
find an algorithm to differentiate between the different GAP
stages. With this approach, we omitted to use pattern-based
classifications coming from known guidelines for pulmonary
fibrosis, as this might not reflect the activity of the disease and
might narrow the diagnosis. By just providing lung function,
age and gender as input parameters, the validation of the al-
gorithm is quite open and thus, best-discriminating radiomics
features might come from feature groups that are not per se
visible or quantifiable by the radiologist.
At present, data on radiomics in ILD are limited. The ac-
cumulating results, however, are promising and underline the
great potential of radiomics in HRCT for detection and stag-
ing. In the future, the use of radiomics in SSc-ILD manage-
ment could be expanded to support treatment decisions.
Future studies integrating both radiomics and tissue-based
molecular information, however, will be needed to assess
whether radiomics reflect the underlying pathophysiology
and thereby allow distinguishing inflammatory from fibrotic
processes. This would be the prerequisite for treatment guid-
ance toward anti-inflammatory or anti-fibrotic drugs in the
individual patient.
The limitations of this study include as follows: firstly,
the GAP staging system consists of three stages (low, in-
termediate, high). We only have patients with GAP stages
1 and 2 in our cohort and the percentage of patients with
GAP stage 2 is relatively small, thereby reflecting the prev-
alence of GAP1 versus GAP2 stage in our clinical popula-
tion. We performed a data augmentation step in order to
achieve better class balance and to avoid model overfitting.
Secondly, we only evaluated data from one institution ac-
quired with one CT scanner. Since differences in scanning
parameters such as type of CT scanner, tube voltage, tube
current, reconstruction kernel, and contrast agent may in-
fluence the results of quantitative analysis, our approach
might need to be adapted for future use with other scanners
and protocols. Further studies with higher patient numbers,
on other scanners, are needed to validate our findings and
to investigate potential outcome predictors in a longitudi-
nal study setting. Thirdly, we chose the right lung for im-
age evaluation. Even though evaluation of the left site in
our patient population (see Supplemental material) showed
comparable results between the two sides, we prefer to use
the right lung for image evaluation, since the left lung, due
to the proximity of the left lower lobe and lingula to the
heart, might be more prone to motion artifacts due to car-
diac pulsation and might therefore deliver less robust re-
sults. We acknowledge that in cases with asymmetrical
lung involvement, this approach might alter the results.
Finally, lung segmentation was performed semiautomati-
cally. This approach gave us the opportunity to correct
datasets, where automatically registered borders did not
correspond with lung borders.
Conclusion
The correlation of radiomics with GAP stage, yet not
with the visually defined features of ILD-HRCT, implies
that radiomics might capture features indicating severity
of SSc-ILD on HRCT, which are not recognized by
visual analysis.
The texture-based radiomics features identified in this pilot
study will pave the way for the assessment whether texture-
based radiomics signatures may be valuable tools for
computer-aided decision-making in imaging.
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